Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva CEO Has Doubts About Making Generic-Drug Ingredients in the U.S. | Barron's
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva's Buffett Bump Fades After He Says Investment Wasn't His Idea - Bloomberg
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Teva Makes $40.1 Billion Unsolicited Takeover Bid for Mylan - Bloomberg
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva Is Exploring Mylan Bid to Create Generic-Drug Giant - Bloomberg
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges
The Difficulties of Cloning a CEO - Bloomberg
Teva Picked as Bellwether Target in Generic Drug Price-Fix Case
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case - Bloomberg Law
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Soriot not moving to Teva - Bloomberg - Globes
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Faces Securities Class Action Alleging Copaxone Kickbacks
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
